Literature DB >> 17143960

Splenectomy with endoscopic variceal ligation is superior to splenectomy with pericardial devascularization in treatment of portal hypertension.

Nan Lin1, Bo Liu, Rui-Yun Xu, He-Ping Fang, Mei-Hai Deng.   

Abstract

AIM: To investigate the therapeutic efficacy and complications of splenectomy with endoscopic variceal ligation (EVL) and splenectomy with pericardial devascularization (i.e. Hassab's operation) in patients with portal hypertension.
METHODS: A total of 103 patients with liver cirrhosis and portal hypertension were randomly selected to receive either splenectomy with EVL (n = 53, group A) or Hassab's operation (n = 50, group B).
RESULTS: The portal blood flow volume, the presence of portal vein thrombosis, gastric emptying time and free portal venous pressure (FPP) before and after the operation were determined. Patients were followed up for up to 64 mo with an average of 45 mo, and the Dagradi classification of variceal veins and the grading of portal hypertension gastropathy (PHG) were evaluated. It was found that all esophageal varices were occluded or decreased to grade II or less in both groups. There was little difference in the recurrence rate of esophageal varices (11.9% vs 13.2%) and the re-bleeding rate (7.1% vs 5.3%) between groups A and B. The incidence of complications and the percentage of patients with severe PHG after the operation were significantly higher in group B (60.0% and 52.0%) than in group A (32.1% and 20.8%, P < 0.05). No patients died of operation-related complications. There was no significant difference in gastric emptying time, FPP and portal blood flow volume between the two groups.
CONCLUSION: The results suggest that splenectomy with EVL achieves similar therapeutic efficacy to that of Hassab's operation in terms of the recurrence rate of esophageal varices and the re-bleeding rate, but the former results in fewer and milder complications.

Entities:  

Mesh:

Year:  2006        PMID: 17143960      PMCID: PMC4087502          DOI: 10.3748/wjg.v12.i45.7375

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices.

Authors:  D Baroncini; G L Milandri; D Borioni; A Piemontese; V Cennamo; P Billi; P P Dal Monte; N D'Imperio
Journal:  Endoscopy       Date:  1997-05       Impact factor: 10.093

2.  Observer variability in echo-Doppler measurements of portal flow in cirrhotic patients and normal volunteers.

Authors:  C Sabbá; G G Weltin; D V Cicchetti; G Ferraioli; K J Taylor; T Nakamura; F Moriyasu; R J Groszmann
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

3.  Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study.

Authors:  A Avgerinos; A Armonis; S Manolakopoulos; G Poulianos; G Rekoumis; A Sgourou; P Gouma; S Raptis
Journal:  J Hepatol       Date:  1997-05       Impact factor: 25.083

4.  "Congestion index" of the portal vein.

Authors:  F Moriyasu; O Nishida; N Ban; T Nakamura; M Sakai; T Miyake; H Uchino
Journal:  AJR Am J Roentgenol       Date:  1986-04       Impact factor: 3.959

5.  Portal pressure measurements before and after Hassab's decongestion operation. A preliminary report.

Authors:  K Karara; M A el-Gendi; P Gertsch; R Mosimann
Journal:  Int Surg       Date:  1987 Jul-Sep

Review 6.  Current role of surgery for the treatment of portal hypertension.

Authors:  Héctor Orozco; Miguel Angel Mercado; Carlos Chan; Guillermo Ramos-Gallard; Raúl Gálvez-Treviño; Noel Salgado-Nesme; Roberto Cisneros De-ajuria; Francisco Javier Anthón
Journal:  Ann Hepatol       Date:  2002 Oct-Dec       Impact factor: 2.400

7.  Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?

Authors:  T T McCormack; J Sims; I Eyre-Brook; H Kennedy; J Goepel; A G Johnson; D R Triger
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

8.  Measurement of portal vascular resistance in patients with portal hypertension.

Authors:  F Moriyasu; O Nishida; N Ban; T Nakamura; K Miura; M Sakai; T Miyake; H Uchino
Journal:  Gastroenterology       Date:  1986-03       Impact factor: 22.682

9.  Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors.

Authors:  Wei-Dong Pan; Rui-Yun Xun; You-Ming Chen
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2002-11

10.  Three years experience with endoscopic variceal ligation for treatment of bleeding varices.

Authors:  J S Goff; R M Reveille; G V Stiegmann
Journal:  Endoscopy       Date:  1992-06       Impact factor: 10.093

View more
  9 in total

1.  Percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization for the treatment of variceal bleeding and hypersplenism.

Authors:  Wei-Dong Gong; Ke Xue; Yuan-Kui Chu; Qing Wang; Wei Yang; Hui Quan; Peng Yang; Zhi-Min Wang; Zhi-Qun Wu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Combined Laparoscopic Splenectomy and Esophagogastric Devascularization versus Open Splenectomy and Esophagogastric Devascularization for Portal Hypertension due to Liver Cirrhosis.

Authors:  Hong-Ping Luo; Zhan-Guo Zhang; Xin Long; Fei-Long Liu; Xiao-Ping Chen; Lei Zhang; Wan-Guang Zhang
Journal:  Curr Med Sci       Date:  2020-03-13

3.  Splanchnic Vein Thrombosis in Liver Cirrhosis After Splenectomy or Splenic Artery Embolization: A Systematic Review and Meta-Analysis.

Authors:  Yanyan Wu; Hongyu Li; Tiansong Zhang; Zhaohui Bai; Xiangbo Xu; Giovanni Battista Levi Sandri; Le Wang; Xingshun Qi
Journal:  Adv Ther       Date:  2021-03-09       Impact factor: 3.845

4.  Splenectomy Combined with Endoscopic Variceal Ligation (EVL) versus EVL Alone for Secondary Prophylaxis of Variceal Bleeding in Hepatosplenic Schistosomiasis: A Retrospective Case-Control Study.

Authors:  Jolivet Auguste Rakotomalala; Chantelli Iamblaudiot Razafindrazoto; Nitah Harivony Randriamifidy; Behoavy Mahafaly Ralaizanaka; Sonny Maherison; Domoina Harivonjy Hasina Laingonirina; Mialitiana Rakotomaharo; Anjaramalala Sitraka Rasolonjatovo; Mamisoa Anicet Rakotovao; Andry Lalaina Rinà Rakotozafindrabe; Tovo Harimanana Rabenjanahary; Rija Fanantenantsoa; Soloniaina Hélio Razafimahefa; Rado Manitrala Ramanampamonjy
Journal:  Hepat Med       Date:  2022-05-18

5.  Laparoscopic splenectomy plus preoperative endoscopic variceal ligation versus splenectomy with pericardial devascularization (Hassab's operation) for control of severe varices due to portal hypertension.

Authors:  Jin Zhou; Zhong Wu; Junchao Wu; Bing Peng; Xin Wang; Mingjun Wang
Journal:  Surg Endosc       Date:  2013-07-12       Impact factor: 4.584

6.  Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.

Authors:  Maria Corina Plaz Torres; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Davide Roccarina; Amine Benmassaoud; Laura Iogna Prat; Norman R Williams; Mario Csenar; Dominic Fritche; Tanjia Begum; Sivapatham Arunan; Maxine Tapp; Elisabeth Jane Milne; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30

7.  Liver Retraction Using n-Butyl-2-Cyanoacrylate (NBCA) Glue during Laparoscopic Splenectomy and Azygoportal Disconnection in Cirrhotic Patients.

Authors:  Du Kong; Wei Wang; Gang Du; Binyao Shi; Zhengchen Jiang; Bin Jin
Journal:  Biomed Res Int       Date:  2018-08-19       Impact factor: 3.411

8.  Laparoscopic RFA with splenectomy for hepatocellular carcinoma.

Authors:  Kunpeng Hu; Purun Lei; Zhicheng Yao; Chenhu Wang; Qingliang Wang; Shilei Xu; Zhiyong Xiong; He Huang; Ruiyun Xu; Meihai Deng; Bo Liu
Journal:  World J Surg Oncol       Date:  2016-07-27       Impact factor: 2.754

Review 9.  Laparoscopic Splenectomy and Azygoportal Disconnection: a Systematic Review.

Authors:  Guo-Qing Jiang; Dou-Sheng Bai; Ping Chen; Jian-Jun Qian; Sheng-Jie Jin
Journal:  JSLS       Date:  2015 Oct-Dec       Impact factor: 2.172

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.